Stories similar to TB, pneumonia vaccines launched in Africa:

Global Vaccine Market Forecast to 2012 2 years 47 weeks ago

Vaccines have emerged as one of the most lucrative segment in the global pharmaceutical industry. With a projected CAGR of over 13% during 2009-2012, the industry will emerge as the fastest growing therapy area. The US and Europe represent the two largest vaccine markets in the world and will continue experiencing healthy growth rate in future.

Study links the ingredient Thimerosal in H1N1 vaccine to brain injury 2 years 21 weeks ago

Neuro Toxicology recently published a new study that lends further credibility to parents and scientist who question the increasingly aggressive childhood vaccine schedule and toxic vaccine ingredients.

A research team at the University of Pittsburgh found that infant macaque monkeys receiving a single Hepatitis B vaccine containing the mercury-based preservative thimerosal showed significant delays in developing critical reflexes controlled by the brainstem. This was in sharp contrast to the control group who developed normally but did not receive the vaccines.

Combo vaccine reduces risk of HIV infection, researchers say 2 years 34 weeks ago

New vaccine cut risk of HIV infection by 31 percent in world's largest HIV trial
Combination of prime, booster vaccines prove effective, researchers say
Researchers tested strains in Thailand; not known if vaccine would work elsewhere

NEW "SWINE" FLU, what caused it & NATURAL PREVENTION and CURE 2 years 24 weeks ago

This year Baxter send flu-vaccine contaminated with bird flu in Europe countries
In the February 2009, in Europe happened the following:

American company Baxter flu vaccines contaminated with H5N1 - otherwise known as the human form of avian flu, one of the most deadly biological weapons on earth with a 60% kill rate - were received by labs in the

Czech Republic,
Austria,
Germany and
Slovenia.

Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry 2 years 20 weeks ago

The global market for human vaccines has experienced strong growth through 2008 and this is expected to continue through the forecast period. Growth will be fueled by new product introductions and rising usage in all regions.